Table of Content

1 Bovine Rotavirus Vaccine Market Overview
1.1 Product Overview and Scope of Bovine Rotavirus Vaccine
1.2 Bovine Rotavirus Vaccine Segment by Type
1.2.1 Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Bovine Rotavirus Vaccine Segment by Application
1.3.1 Global Bovine Rotavirus Vaccine Market Value by Application: (2024-2034)
1.3.2 Calf
1.3.3 Adult Cow
1.4 Global Bovine Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Bovine Rotavirus Vaccine Revenue 2024-2034
1.4.2 Global Bovine Rotavirus Vaccine Sales 2024-2034
1.4.3 Global Bovine Rotavirus Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Bovine Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Bovine Rotavirus Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Bovine Rotavirus Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Bovine Rotavirus Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Bovine Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bovine Rotavirus Vaccine, Product Type & Application
2.7 Bovine Rotavirus Vaccine Market Competitive Situation and Trends
2.7.1 Bovine Rotavirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bovine Rotavirus Vaccine Players Market Share by Revenue
2.7.3 Global Bovine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bovine Rotavirus Vaccine Retrospective Market Scenario by Region
3.1 Global Bovine Rotavirus Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Bovine Rotavirus Vaccine Global Bovine Rotavirus Vaccine Sales by Region: 2024-2034
3.2.1 Global Bovine Rotavirus Vaccine Sales by Region: 2024-2024
3.2.2 Global Bovine Rotavirus Vaccine Sales by Region: 2024-2034
3.3 Global Bovine Rotavirus Vaccine Global Bovine Rotavirus Vaccine Revenue by Region: 2024-2034
3.3.1 Global Bovine Rotavirus Vaccine Revenue by Region: 2024-2024
3.3.2 Global Bovine Rotavirus Vaccine Revenue by Region: 2024-2034
3.4 North America Bovine Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Bovine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Bovine Rotavirus Vaccine Sales by Country (2024-2034)
3.4.3 North America Bovine Rotavirus Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bovine Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Bovine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Bovine Rotavirus Vaccine Sales by Country (2024-2034)
3.5.3 Europe Bovine Rotavirus Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bovine Rotavirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Bovine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Bovine Rotavirus Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Bovine Rotavirus Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bovine Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Bovine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Bovine Rotavirus Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Bovine Rotavirus Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bovine Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bovine Rotavirus Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Bovine Rotavirus Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Bovine Rotavirus Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bovine Rotavirus Vaccine Sales by Type (2024-2034)
4.1.1 Global Bovine Rotavirus Vaccine Sales by Type (2024-2024)
4.1.2 Global Bovine Rotavirus Vaccine Sales by Type (2024-2034)
4.1.3 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Bovine Rotavirus Vaccine Revenue by Type (2024-2034)
4.2.1 Global Bovine Rotavirus Vaccine Revenue by Type (2024-2024)
4.2.2 Global Bovine Rotavirus Vaccine Revenue by Type (2024-2034)
4.2.3 Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Bovine Rotavirus Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Bovine Rotavirus Vaccine Sales by Application (2024-2034)
5.1.1 Global Bovine Rotavirus Vaccine Sales by Application (2024-2024)
5.1.2 Global Bovine Rotavirus Vaccine Sales by Application (2024-2034)
5.1.3 Global Bovine Rotavirus Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Bovine Rotavirus Vaccine Revenue by Application (2024-2034)
5.2.1 Global Bovine Rotavirus Vaccine Revenue by Application (2024-2024)
5.2.2 Global Bovine Rotavirus Vaccine Revenue by Application (2024-2034)
5.2.3 Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Bovine Rotavirus Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Zoetis Bovine Rotavirus Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 MSD Animal Health
6.2.1 MSD Animal Health Corporation Information
6.2.2 MSD Animal Health Description and Business Overview
6.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolio
6.2.5 MSD Animal Health Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 GSK Bovine Rotavirus Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Boehringer-Ingelheim
6.4.1 Boehringer-Ingelheim Corporation Information
6.4.2 Boehringer-Ingelheim Description and Business Overview
6.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolio
6.4.5 Boehringer-Ingelheim Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Merck Animal Health
6.6.1 Merck Animal Health Corporation Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolio
6.6.5 Merck Animal Health Recent Developments/Updates
6.7 Elanco Animal Health
6.6.1 Elanco Animal Health Corporation Information
6.6.2 Elanco Animal Health Description and Business Overview
6.6.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolio
6.7.5 Elanco Animal Health Recent Developments/Updates
6.8 Pharmgal Bio
6.8.1 Pharmgal Bio Corporation Information
6.8.2 Pharmgal Bio Description and Business Overview
6.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolio
6.8.5 Pharmgal Bio Recent Developments/Updates
6.9 Creative Biolabs
6.9.1 Creative Biolabs Corporation Information
6.9.2 Creative Biolabs Description and Business Overview
6.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolio
6.9.5 Creative Biolabs Recent Developments/Updates
6.10 Lanzhou Institute of Biological Products
6.10.1 Lanzhou Institute of Biological Products Corporation Information
6.10.2 Lanzhou Institute of Biological Products Description and Business Overview
6.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolio
6.10.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.11 Weike Biotechnology
6.11.1 Weike Biotechnology Corporation Information
6.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Description and Business Overview
6.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolio
6.11.5 Weike Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bovine Rotavirus Vaccine Industry Chain Analysis
7.2 Bovine Rotavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bovine Rotavirus Vaccine Production Mode & Process
7.4 Bovine Rotavirus Vaccine Sales and Marketing
7.4.1 Bovine Rotavirus Vaccine Sales Channels
7.4.2 Bovine Rotavirus Vaccine Distributors
7.5 Bovine Rotavirus Vaccine Customers
8 Bovine Rotavirus Vaccine Market Dynamics
8.1 Bovine Rotavirus Vaccine Industry Trends
8.2 Bovine Rotavirus Vaccine Market Drivers
8.3 Bovine Rotavirus Vaccine Market Challenges
8.4 Bovine Rotavirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Bovine Rotavirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Bovine Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Bovine Rotavirus Vaccine Sales (K Doses) of Key Manufacturers (2024-2024)
Table 5. Global Bovine Rotavirus Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Bovine Rotavirus Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Bovine Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Bovine Rotavirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Bovine Rotavirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bovine Rotavirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Bovine Rotavirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bovine Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Rotavirus Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bovine Rotavirus Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Bovine Rotavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 18. Global Bovine Rotavirus Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Bovine Rotavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 20. Global Bovine Rotavirus Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Bovine Rotavirus Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Bovine Rotavirus Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Bovine Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Bovine Rotavirus Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Bovine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Bovine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 27. North America Bovine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 28. North America Bovine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Bovine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Bovine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Bovine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 32. Europe Bovine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 33. Europe Bovine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Bovine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Bovine Rotavirus Vaccine Sales by Region (2024-2024) & (K Doses)
Table 37. Asia Pacific Bovine Rotavirus Vaccine Sales by Region (2024-2034) & (K Doses)
Table 38. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Bovine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Bovine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 42. Latin America Bovine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 43. Latin America Bovine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Bovine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2024-2024) & (K Doses)
Table 47. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2024-2034) & (K Doses)
Table 48. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Bovine Rotavirus Vaccine Sales (K Doses) by Type (2024-2024)
Table 51. Global Bovine Rotavirus Vaccine Sales (K Doses) by Type (2024-2034)
Table 52. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2024)
Table 59. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2034)
Table 60. Global Bovine Rotavirus Vaccine Sales (K Doses) by Application (2024-2024)
Table 61. Global Bovine Rotavirus Vaccine Sales (K Doses) by Application (2024-2034)
Table 62. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2024)
Table 69. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2034)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 73. Zoetis Bovine Rotavirus Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. MSD Animal Health Corporation Information
Table 76. MSD Animal Health Description and Business Overview
Table 77. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 78. MSD Animal Health Bovine Rotavirus Vaccine Product
Table 79. MSD Animal Health Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 83. GSK Bovine Rotavirus Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Boehringer-Ingelheim Corporation Information
Table 86. Boehringer-Ingelheim Description and Business Overview
Table 87. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 88. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product
Table 89. Boehringer-Ingelheim Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 93. Serum Institute of India Bovine Rotavirus Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Merck Animal Health Corporation Information
Table 96. Merck Animal Health Description and Business Overview
Table 97. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 98. Merck Animal Health Bovine Rotavirus Vaccine Product
Table 99. Merck Animal Health Recent Developments/Updates
Table 100. Elanco Animal Health Corporation Information
Table 101. Elanco Animal Health Description and Business Overview
Table 102. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 103. Elanco Animal Health Bovine Rotavirus Vaccine Product
Table 104. Elanco Animal Health Recent Developments/Updates
Table 105. Pharmgal Bio Corporation Information
Table 106. Pharmgal Bio Description and Business Overview
Table 107. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 108. Pharmgal Bio Bovine Rotavirus Vaccine Product
Table 109. Pharmgal Bio Recent Developments/Updates
Table 110. Creative Biolabs Corporation Information
Table 111. Creative Biolabs Description and Business Overview
Table 112. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 113. Creative Biolabs Bovine Rotavirus Vaccine Product
Table 114. Creative Biolabs Recent Developments/Updates
Table 115. Lanzhou Institute of Biological Products Corporation Information
Table 116. Lanzhou Institute of Biological Products Description and Business Overview
Table 117. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 118. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product
Table 119. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 120. Weike Biotechnology Corporation Information
Table 121. Weike Biotechnology Description and Business Overview
Table 122. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2024)
Table 123. Weike Biotechnology Bovine Rotavirus Vaccine Product
Table 124. Weike Biotechnology Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Bovine Rotavirus Vaccine Distributors List
Table 128. Bovine Rotavirus Vaccine Customers List
Table 129. Bovine Rotavirus Vaccine Market Trends
Table 130. Bovine Rotavirus Vaccine Market Drivers
Table 131. Bovine Rotavirus Vaccine Market Challenges
Table 132. Bovine Rotavirus Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bovine Rotavirus Vaccine
Figure 2. Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Bovine Rotavirus Vaccine Market Share by Type in 2022 & 2034
Figure 4. Attenuated Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global Bovine Rotavirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Bovine Rotavirus Vaccine Market Share by Application in 2022 & 2034
Figure 8. Calf
Figure 9. Adult Cow
Figure 10. Global Bovine Rotavirus Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Bovine Rotavirus Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Bovine Rotavirus Vaccine Sales (2024-2034) & (K Doses)
Figure 13. Global Bovine Rotavirus Vaccine Average Price (US$/Dose) & (2024-2034)
Figure 14. Bovine Rotavirus Vaccine Report Years Considered
Figure 15. Bovine Rotavirus Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Bovine Rotavirus Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Bovine Rotavirus Vaccine Players: Market Share by Revenue in 2022
Figure 18. Bovine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Bovine Rotavirus Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Bovine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Bovine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Bovine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Bovine Rotavirus Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Bovine Rotavirus Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Bovine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Bovine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Bovine Rotavirus Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Bovine Rotavirus Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Bovine Rotavirus Vaccine by Type (2024-2034)
Figure 52. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2024-2034)
Figure 53. Global Sales Market Share of Bovine Rotavirus Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Bovine Rotavirus Vaccine by Application (2024-2034)
Figure 55. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2024-2034)
Figure 56. Bovine Rotavirus Vaccine Value Chain
Figure 57. Bovine Rotavirus Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed